SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
10-Sep-24 4:32 PM View: | Entrada Therapeutics, Inc. (TRDA) | 09-Sep-24 | Sale (Planned) | 2,642 | $15.09 | $39,862.20 | (1%) 186.46K to 183.82K | |
10-Sep-24 4:32 PM View: | Entrada Therapeutics, Inc. (TRDA) | 06-Sep-24 | Private Sale (Planned) | 600 | $15.24 | $9,141.36 | (< 1%) 187.06K to 186.46K | |
05-Sep-24 6:47 PM View: | Entrada Therapeutics, Inc. (TRDA) | 05-Sep-24 | Payment of Exercise | 167 | $15.13 | $2,526.04 | (< 1%) 187.22K to 187.06K | |
05-Sep-24 6:47 PM View: | Entrada Therapeutics, Inc. (TRDA) | 04-Sep-24 | Payment of Exercise | 955 | $15.42 | $14,729.30 | (< 1%) 188.18K to 187.22K | |
05-Sep-24 6:47 PM View: | Entrada Therapeutics, Inc. (TRDA) | 03-Sep-24 | Payment of Exercise | 634 | $16.08 | $10,195.50 | (< 1%) 188.81K to 188.18K | |
16-Jul-24 4:43 PM View: | Entrada Therapeutics, Inc. (TRDA) | 15-Jul-24 | Sale (Planned) | 638 | $18.00 | $11,484.00 | (< 1%) 189.45K to 188.81K | |
16-Jul-24 4:43 PM View: | Entrada Therapeutics, Inc. (TRDA) | 12-Jul-24 | Private Sale (Planned) | 600 | $18.00 | $10,800.00 | (< 1%) 190.05K to 189.45K | |
20-May-24 5:26 PM View: | Entrada Therapeutics, Inc. (TRDA) | 20-May-24 | Sale (Planned) | 9,675 | $15.19 | $146,944.00 | (5%) 199.73K to 190.05K | |
20-May-24 5:26 PM View: | Entrada Therapeutics, Inc. (TRDA) | 17-May-24 | Sale (Planned) | 8,305 | $15.14 | $125,751.00 | (4%) 208.03K to 199.73K | |
20-May-24 5:26 PM View: | Entrada Therapeutics, Inc. (TRDA) | 16-May-24 | Private Sale (Planned) | 1,000 | $15.00 | $15,000.00 | (< 1%) 209.03K to 208.03K | |
05-Mar-24 7:44 PM View: | Entrada Therapeutics, Inc. (TRDA) | 05-Mar-24 | Payment of Exercise | 1,505 | $12.28 | $18,479.60 | (< 1%) 210.54K to 209.03K | |
05-Mar-24 7:44 PM View: | Entrada Therapeutics, Inc. (TRDA) | 04-Mar-24 | Payment of Exercise | 761 | $12.94 | $9,844.84 | (< 1%) 211.3K to 210.54K | |
05-Mar-24 7:44 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Mar-24 | Grant | 44,100 | -- | -- | 26% 167.2K to 211.3K | |
06-Sep-23 5:09 PM View: | Entrada Therapeutics, Inc. (TRDA) | 05-Sep-23 | Payment of Exercise | 449 | $14.46 | $6,493.66 | (< 1%) 167.65K to 167.2K | |
06-Sep-23 5:09 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Sep-23 | Grant | 14,200 | -- | -- | 9% 153.45K to 167.65K | |
12-Jul-23 4:32 PM View: | Entrada Therapeutics, Inc. (TRDA) | 11-Jul-23 | Sale (Planned) | 14,852 | $18.04 | $267,915.00 | (9%) 168.3K to 153.45K | |
12-Jul-23 4:32 PM View: | Entrada Therapeutics, Inc. (TRDA) | 10-Jul-23 | Private Sale (Planned) | 3,026 | $18.00 | $54,474.10 | (2%) 171.32K to 168.3K | |
19-Apr-23 6:06 PM View: | Entrada Therapeutics, Inc. (TRDA) | 17-Apr-23 | Private Sale (Planned) | 3,961 | $18.00 | $71,315.80 | (2%) 175.29K to 171.32K | |
03-Mar-23 4:36 PM View: | Entrada Therapeutics, Inc. (TRDA) | 02-Mar-23 | Payment of Exercise | 1,058 | $11.60 | $12,268.80 | (< 1%) 190.54K to 189.49K | |
03-Mar-23 4:36 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Mar-23 | Grant | 28,400 | -- | -- | 18% 162.14K to 190.54K | |
06-Sep-22 4:33 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Sep-22 | Grant | 5,794 | -- | -- | 4% 156.35K to 162.14K | |
03-Mar-22 4:10 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Mar-22 | Grant | 11,588 | -- | -- | 8% 144.76K to 156.35K |